Stock News, US News

14 companies are planned to go public this week (12 Jul – 16 Jul)

Blend Labs (BLND) [2012]

Software & Tech Services | 20,000,000 shares | $16.00 – $18.00 | NYSE | Series G | $665M funded

Blend is a digital lending platform that supports and simplifies applications for mortgages, consumer loans, and deposit accounts.

Notify me when BLND goes public

The expected IPO date is Friday, July 16th, 2021

Sight Sciences (SGHT) [2011]

Tech Hardware & Semiconductors | 6,980,000 shares | $20.00 – $23.00 | Nasdaq | $108.7M funded

Sight Sciences is a medical device company that uses a computer-based device designed for the treatment of eye disease.

Notify me when SGHT goes public

The expected IPO date is Thursday, July 15th, 2021

Bridge Investment Group (BRDG) [2009]

Financial Services | 18,750,000 shares | $15.00 – $17.00 | NYSE

Bridge Investment Group (“Bridge”) is a leading privately held real estate investment and property management firm.

Notify me when BRDG goes public

The expected IPO date is Friday, July 16th, 2021

F45 Training (FXLV) [2012]

Consumer Discretionary Services | 20,312,500 shares | $15.00 – $17.00 | NYSE

F45 Training is the world’s fastest growing fitness network.

Notify me when FXLV goes public

The expected IPO date is Thursday, July 15th, 2021

Membership Collective Group (MCG) [2021]

Software & Tech Services | 30,000,000 shares | $14.00 – $16.00 | NYSE

Membership Collective Group Inc. is a global membership platform. The Company offers platform of physical and digital spaces that connects a diverse group of members to work, socialize, and flourish all over the world.

Notify me when MCG goes public

The expected IPO date is Thursday, July 15th, 2021

Phillips Edison & Company (PECO) [1991]

Real Estate | 17,000,000 shares | $28.00 – $31.00 | Nasdaq | $200M funded

Phillips Edison & Company is an internally-managed real estate investment trust (REIT).

Notify me when PECO goes public

The expected IPO date is Friday, July 16th, 2021

Sera Prognostics (SERA) [2008]

Health Care | 4,687,500 shares | $15.00 – $17.00 | Nasdaq | Series E | $250.3M funded

Sera Prognostics develops blood tests that are predictive of preterm birth, preeclampsia, and other pregnancy complications.

Notify me when SERA goes public

The expected IPO date is Thursday, July 15th, 2021

Stevanato Group (STVN) [1949]

Materials | 40,000,000 shares | $21.00 – $24.00 | NYSE

Stevanato Group S.p.A. manufactures packaging containers from glass tubing for the pharmaceutical industry worldwide.

Notify me when STVN goes public

The expected IPO date is Friday, July 16th, 2021

Unicycive Therapeutics (UNCY) [2016]

Health Care | 4,550,000 shares | $5.00 – $6.00 | Nasdaq | Series A | $6M funded

Unicycive Therapeutics provides development programs that focus on treating kidney diseases with significant unmet medical needs.

Notify me when UNCY goes public

Erasca (ERAS) [2018]

Biotech & Pharma | 17,500,000 shares | $14.00 – $16.00 | Nasdaq | Series B | $300M funded

Erasca is a developer of oncology drugs intended to provide precision oncology options.

Notify me when ERAS goes public

Imago BioSciences (IMGO) [2012]

Biotech & Pharma | 7,000,000 shares | $14.00 – $16.00 | Nasdaq | Series C | $146.5M funded

Imago BioSciences is a company dedicated to translating state-of-the art science into novel medicines for the treatment of diseases.

Notify me when IMGO goes public

Perspectum Group (SCAN) [2011]

Biotech & Pharma | 4,687,500 shares | $15.00 – $17.00 | Nasdaq | $46.7M funded

Perspectum develops solutions for major unmet needs in diagnostic medicine in multiple internal organs.

Notify me when SCAN goes public

Rapid Micro Biosystems (RPID) [2006]

Biotech & Pharma | 6,600,000 shares | $18.00 – $20.00 | Nasdaq | $358.4M funded

Rapid Micro Biosystems offers tools that detect microbial contamination in manufacturing pharmaceutical, biotechnology and other products.

Notify me when RPID goes public

TScan Therapeutics (TCRX) [2018]

Biotech & Pharma | 6,250,000 shares | $15.00 – $17.00 | Nasdaq | Series C | $137.5M funded

TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.

Notify me when TCRX goes public


Would you like to get an IPO Brief every Monday with first hand insights on upcoming IPOs and get a personal notification when each stock goes public? https://ipobrief.email/

submitted by /u/IPOBrief
[link] [comments]

Jump To The Original Source

Facebook Comments

Check Also

Working from home home can reduce migraine intensity, research shows

Published by DPA Working from home can help ...

Archives